Drug Intoxication & Detoxication : Novel Approaches Open Access

  • Journal h-index: 1
  • Journal CiteScore: 0.19
  • Journal Impact Factor: 0.19
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Commentary - (2023) Volume 4, Issue 2

Uses of Metabolomics in Scientific Toxicology and Forensic Medication
Michael Ciborowski*
Department of Forensic Medicine, Medical University of Bialystok, Poland
*Correspondence: Michael Ciborowski, Department of Forensic Medicine, Medical University of Bialystok, Poland, Email:

Received: 31-May-2023, Manuscript No. DIDNA-23-16834; Editor assigned: 02-Jun-2023, Pre QC No. DIDNA-23-16834 (PQ); Reviewed: 16-Jun-2023, QC No. DIDNA-23-16834; Revised: 21-Jun-2023, Manuscript No. DIDNA-23-13834 (R); Published: 28-Jun-2023, DOI: 10.36648/DIDNA 4.2.14


Scientific toxicology and forensic medicine are unique among other clinical disciplines because they are fundamentally justifiable practices, especially in civil and criminal cases. Recent high-throughput advances in science and physics have shown that metabolomics, the youngest of the ‘omics sciences’, can be one of the most useful tools for examining changes in the criminological field. Metabolomics follows a special strategy that considers the estimation of metabolic changes in multicellular networks using two different methods. Concentrated and unconcentrated. Targeted studies focus on a known number of characterized metabolites. Untargeted metabolomics means capturing all metabolites present in the sample. In both cases, various fact-based methods (univariate or multivariate measurements, AI, etc.) can be applied to obtain useful and meaningful data. The purpose of this audit is to present the challenges of metabolomics in measurable toxicology and scientific medicine.

Metabolomics studies can be performed using a variety of methods. The most comprehensive method is metabolic fingerprinting, which preferably requires quantification of all metabolites present in enriched samples. In principle, the currently used scientific methods cannot quantify all metabolites present in natural samples. Subsequently, we expect to increase metabolome inclusion by combining several methods of decomposing similar examples. Metabolic fingerprinting, also called untargeted metabolomics investigations, can be performed using atom-induced reverberation (NMR) or mass spectrometry (MS) combined with one of the following splitting processes:

Liquid chromatography (LC), gas chromatography (GC), or lean electrophoresis (CE). In contrast to MS, NMR is less reactive but more reproducible. Furthermore, NMR is quantitative in nature and requires a small sample assembly that does not adversely

affect the sample. Different classes of metabolites are distinguished, depending on the elimination strategy associated with MS. GC-MS can be used to quantify metabolites that are labile or that can undergo unpredictable conformational changes. CE-MS helps discover polar and ionogenic metabolites. At the same time, LC-MS can be used to measure polar (hydrophilic liquid chromatography) and non-polar (switch stage chromatography) metabolites, depending on the type of chromatography used. For non-targeted studies, the use of a high-target MS analyzer, usually an Orbitrap or Season-of-Flight (TOF) MS analyzer is required. A similar logical strategy can be used for other metabolomics approaches such as metabolic profiling and metabolite targeting. In any case, these methods estimate recently identified metabolites. Metabolic profiles are metabolites belonging to a particular class (e.g. unsaturated fats, amino acids) or metabolites from particular metabolic pathways (e.g. arachidonic acid and its cyclooxygenase (COX) and lipoxygenase (LOX)-away metabolites).


Traditional investigative strategies may not be persuasive in NPS screening at this time. As the screening approaches, identification of drug use beyond one or more notable metabolites is likely, especially if the parent compound itself is not detected in the sample. However, due to the normal, essential metabolites of some fundamentally related compounds, other minor metabolites may also be important in proving the approval of certain illicit drugs.



Conflict Of Interest

The author’s declared that they have no conflict of interest.

Citation: Ciborowski M (2023) Uses of Metabolomics in Scientific Toxicology and Forensic Medication. Drug Intox Detox: Novel Approaches. 4:14.

Copyright: ©2023 Ciborowski M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.